PLCG2 and non-Hodgkin lymphoma: Previously, we described in-vitro cytotoxicity with the Fc-based 22-(20)-(20) on NHL cell lines resulting from signaling mechanisms involving Lyn, Syk, PLCγ2, AKT and NF-κB pathways leading to apoptosis via signaling transduction mechanisms [49], [50].